Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

Matching articles

Showing 1–12 of 134 articles · Explore study findings

Clear search and filters

  • Explore study findings

    Why Amyloid Beta Fibrils Can Have Different Shapes

    Amyloid beta is a family of peptides cut from amyloid precursor protein. Some forms can assemble into long fibers, called fibrils, in which many copies of the peptide align. A label such as A4 Amyloid Beta leaves both the sequence and whether the peptide is already assembled unspecified.

    A4 Amyloid Beta1 source (2026)

  • Explore study findings

    What Amyloid Beta Ratios in Blood Can Reveal Before a Scan Changes

    The amyloid beta family includes Aβ42 and Aβ40, two products of the same precursor that differ in length. The ratio of those two forms in plasma is a measurement of circulating peptides. An amyloid PET scan, by contrast, measures a tracer signal associated with deposited amyloid in the brain.

    A4 Amyloid Beta2 sources (2026)

  • Explore study findings

    What Donanemab Follow Up Teaches About Targeting Amyloid Beta

    Amyloid beta is a family of peptides produced from a larger membrane protein. Some forms build up in deposits called plaques. Donanemab is an antibody that targets a form of amyloid beta in those deposits. It is the intervention in the research described here; amyloid beta is the target.

    A4 Amyloid Beta1 source (2025)

  • Explore study findings

    What a Rare APP Mutation Reveals About Amyloid in Brain Blood Vessels

    Amyloid beta is cut from amyloid precursor protein, or APP, so a change in the gene for APP can change the peptide itself. A rare inherited variant called the Flemish mutation changes position 21 in Aβ from alanine to glycine.

    A4 Amyloid Beta1 source (2026)

  • Explore study findings

    What changed on scans of healthy volunteers

    ACE-031 is a larger investigational fusion protein that binds myostatin and other signals involved in regulating muscle. An older first-in-human study in healthy postmenopausal volunteers provides a direct look at the body composition changes that first drew attention to the molecule.

    ACE-0311 source (2012)

  • Explore study findings

    Did ACE-031 change muscle fiber type or size?

    ACE-031 is a fusion protein built from part of activin receptor type IIB and an antibody Fc region. Its ability to capture several growth regulators led researchers to ask whether it changes the kinds of fibers in a muscle or primarily changes their size.

    ACE-0312 sources (2010, 2026)

  • Explore study findings

    What the Charcot-Marie-Tooth trial learned from the ankle

    ACE-083 is a larger engineered protein that combines a form of follistatin with an antibody Fc region. It was investigated for local muscle growth.

    ACE-0831 source (2022)

  • Explore study findings

    What healthy volunteers revealed about a local effect

    ACE-083 is a larger follistatin-based fusion protein developed to trap signals in the tissue where it was placed. Its 2018 first-in-human study asked how healthy volunteers tolerated it and whether a selected muscle changed in volume.

    ACE-0832 sources (2018, 2022)

  • Explore study findings

    What mouse models could reveal about contraction

    ACE-083 is a larger engineered follistatin fusion protein built to capture several growth-regulating proteins locally. A 2019 animal study asked whether muscle enlargement after ACE-083 came with a change in the force that the same muscle could produce.

    ACE-0832 sources (2019, 2022)

  • Explore study findings

    What a 2026 study revealed about adipotide’s target

    Adipotide is an experimental construct with two linked peptide segments. One was designed to recognize a form of a protein called prohibitin-1 at the surface of blood vessels that supply white fat. The other can trigger programmed cell death after entering a cell.

    Adipotide2 sources (2011, 2026)

  • Explore study findings

    Why the adipotide kidney findings mattered

    Adipotide is an investigational two-part peptide construct designed to reach white fat blood vessels and trigger programmed cell death there. The older direct studies illustrate why a report on where a peptide is intended to act belongs alongside observations of which organs actually respond.

    Adipotide2 sources (2010–2019)

  • Explore study findings

    What changed when researchers put the peptide cargo in a nanoparticle

    Adipotide connects a fat-vessel-targeting segment directly to a segment that triggers cell death. An older mouse experiment compared this linked design with a delivery particle carrying a similar payload and displaying the targeting peptide on its surface.

    Adipotide1 source (2013)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)